What is the share price of Mankind Pharma Ltd (MANKIND) today?
The share price of MANKIND as on 19th June 2026 is ₹2414.20. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Mankind Pharma Ltd (MANKIND) share?
The past returns of Mankind Pharma Ltd (MANKIND) share are- Past 1 week: -0.20%
- Past 1 month: -3.59%
- Past 3 months: 20.66%
- Past 6 months: 11.15%
- Past 1 year: 3.83%
- Past 3 years: 41.97%
- Past 5 years: 69.74%
What are the peers or stocks similar to Mankind Pharma Ltd (MANKIND)?
The peers or stocks similar to Mankind Pharma Ltd (MANKIND) include:What is the dividend yield % of Mankind Pharma Ltd (MANKIND) share?
The current dividend yield of Mankind Pharma Ltd (MANKIND) is 0.04.What is the market cap of Mankind Pharma Ltd (MANKIND) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Mankind Pharma Ltd (MANKIND) is ₹99705.49 Cr as of 19th June 2026.What is the 52 week high and low of Mankind Pharma Ltd (MANKIND) share?
The 52-week high of Mankind Pharma Ltd (MANKIND) is ₹2716.50 and the 52-week low is ₹1909.70.What is the PE and PB ratio of Mankind Pharma Ltd (MANKIND) stock?
The P/E (price-to-earnings) ratio of Mankind Pharma Ltd (MANKIND) is 52.12. The P/B (price-to-book) ratio is 6.84.Which sector does Mankind Pharma Ltd (MANKIND) belong to?
Mankind Pharma Ltd (MANKIND) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Mankind Pharma Ltd (MANKIND) shares?
You can directly buy Mankind Pharma Ltd (MANKIND) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Mankind Pharma Ltd
MANKIND Share Price
NSEMANKIND Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MANKIND Performance & Key Metrics
MANKIND Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 52.12 | 6.84 | 0.04% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 41.31 | 6.16 | 0.56% |
from 17 analysts
Price Upside
Earnings Growth
Rev. Growth
MANKIND Company Profile
Mankind Pharma Ltd develops and markets a wide range of pharmaceutical formulations across various therapeutic areas, including anti-infectives and cardiovascular products.
MANKIND Sentiment Analysis
MANKIND Sentiment Analysis
MANKIND Stock Summary · February 2026
Mankind Pharma demonstrated robust growth in Q3 FY26, with an 11.5% year-on-year revenue increase driven by strong performance in chronic therapies and a strategic focus on optimizing its brand portfolio. Despite challenges in the acute therapy segment and concerns over revenue discrepancies, management remains optimistic about sustainable long-term growth, bolstered by improvements in workforce stability and operational efficiency. The company is addressing issues related to primary sales lagging behind secondary sales, while also navigating high net debt levels and the complexities of integrating new personnel into its unique sales culture. As it prepares for future opportunities, particularly in niche markets, Mankind Pharma is committed to enhancing its operational framework to support consistent performance and value creation.
MANKIND Stock Growth Drivers
MANKIND Stock Growth Drivers
7Strong Financial Performance
Mankind Pharma reported significant revenue growth, with Q3 FY '26 revenue increasing by 11.5% year-on-year
Improved Workforce Stability and Team Maturity
Recent strategic changes have led to significant improvements in workforce stability and team maturity. The
MANKIND Stock Challenges
MANKIND Stock Challenges
6Declining Profitability Metrics
The company has reported a decrease in adjusted EBITDA margin to 25.9%, down 170 basis
Challenges in Revenue Growth
Despite a reported revenue increase of 11.5% year-on-year, concerns have been raised regarding the growth
MANKIND Forecast
MANKIND Forecasts
Price
Revenue
Earnings
MANKIND Share Price Forecast
MANKIND Share Price Forecast
All values in ₹
All values in ₹
MANKIND Company Revenue Forecast
MANKIND Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
MANKIND Stock EPS (Earnings Per Share) Forecast
MANKIND Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
MANKIND
MANKIND
Income
Balance Sheet
Cash Flow
MANKIND Income Statement
MANKIND Income Statement
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,681.68 | 2,516.80 | 2,975.75 | 3,173.06 | 3,285.88 | 3,333.02 | 3,653.40 | 3,791.35 | 3,643.16 | 3,560.21 | ||||||||||
| Operating & Other expenses | 2,000.45 | 1,836.27 | 2,196.29 | 2,216.61 | 2,382.80 | 2,400.52 | 2,723.58 | 2,775.83 | 2,754.36 | 2,536.21 | ||||||||||
| EBITDA | 681.23 | 680.53 | 779.46 | 956.45 | 903.08 | 932.50 | 929.82 | 1,015.52 | 888.80 | 1,024.00 | ||||||||||
| Depreciation/Amortization | 109.72 | 99.78 | 102.69 | 100.49 | 187.17 | 230.87 | 218.68 | 221.82 | 222.60 | 223.08 | ||||||||||
| PBIT | 571.51 | 580.75 | 676.77 | 855.96 | 715.91 | 701.63 | 711.14 | 793.70 | 666.20 | 800.92 | ||||||||||
| Interest & Other Items | 9.19 | 9.17 | 10.84 | 7.10 | 220.93 | 190.54 | 170.65 | 169.68 | 157.20 | 141.75 | ||||||||||
| PBT | 562.32 | 571.58 | 665.93 | 848.86 | 494.98 | 511.09 | 540.49 | 624.02 | 509.00 | 659.17 | ||||||||||
| Taxes & Other Items | 108.56 | 100.34 | 129.44 | 195.39 | 114.75 | 90.32 | 102.17 | 112.51 | 100.25 | 104.82 | ||||||||||
| Net Income | 453.76 | 471.24 | 536.49 | 653.47 | 380.23 | 420.77 | 438.32 | 511.51 | 408.75 | 554.35 | ||||||||||
| EPS | 11.33 | 11.76 | 13.39 | 16.31 | 9.46 | 10.19 | 10.62 | 12.39 | 9.90 | 13.44 |
MANKIND Company Updates
Investor Presentation
MANKIND Stock Peers
MANKIND Past Performance & Peer Comparison
MANKIND Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Mankind Pharma Ltd | 52.12 | 6.84 | 0.04% |
| Sun Pharmaceutical Industries Ltd | 38.42 | 6.08 | 0.87% |
| Torrent Pharmaceuticals Ltd | 69.30 | 8.53 | 0.86% |
| Cipla Ltd | 28.15 | 3.16 | 0.96% |
MANKIND Stock Price Comparison
Compare MANKIND with any stock or ETFMANKIND Holdings
MANKIND Shareholdings
MANKIND Promoter Holdings Trend
MANKIND Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
MANKIND Institutional Holdings Trend
MANKIND Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has decreased by 1.10%
MANKIND Shareholding Pattern
MANKIND Shareholding Pattern
MANKIND Shareholding History
MANKIND Shareholding History
Mutual Funds Invested in MANKIND
Mutual Funds Invested in MANKIND
No mutual funds holding trends are available
Top 5 Mutual Funds holding Mankind Pharma Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9704% | Percentage of the fund’s portfolio invested in the stock 1.81% | Change in the portfolio weight of the stock over the last 3 months 0.15% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 24/62 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.8101% | Percentage of the fund’s portfolio invested in the stock 1.70% | Change in the portfolio weight of the stock over the last 3 months 0.95% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 57/104 (+22) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.6527% | Percentage of the fund’s portfolio invested in the stock 1.72% | Change in the portfolio weight of the stock over the last 3 months 0.19% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 23/49 (0) |
Compare 3-month MF holding change on Screener
smallcases containing MANKIND stock
smallcases containing MANKIND stock
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Mankind Pharma Ltd
MANKIND Events
MANKIND Events
MANKIND Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
MANKIND Dividend Trend
No dividend trend available
MANKIND Upcoming Dividends
MANKIND Upcoming Dividends
No upcoming dividends are available
MANKIND Past Dividends
MANKIND Past Dividends
Cash Dividend
Ex DateEx DateAug 8, 2025
Dividend/Share
₹1.00
Ex DateEx Date
Aug 8, 2025
MANKIND Stock News & Opinions
MANKIND Stock News & Opinions
Mankind Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2412.2, down 0.47% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.11% on the day, quoting at 23888.4. The Sensex is at 75882.34, down 0.17%.Mankind Pharma Ltd has gained around 6.53% in last one month.Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has increased around 6.66% in last one month and is currently quoting at 24659.2, up 0.16% on the day. The volume in the stock stood at 3.04 lakh shares today, compared to the daily average of 7.96 lakh shares in last one month. The benchmark June futures contract for the stock is quoting at Rs 2429.3, down 0.46% on the day. Mankind Pharma Ltd tumbled 2.88% in last one year as compared to a 3.49% slide in NIFTY and a 15.46% spurt in the Nifty Pharma index.The PE of the stock is 47.06 based on TTM earnings ending March 26.Powered by Capital Market - Live
Mankind Pharma has allotted 80,872 equity shares under ESOP on 19 May 2026. Consequently, the paid up equity share capital has increased to 41,29,09,200 equity shares having face value of Re 1/- each.
Net profit of Mankind Pharma rose 31.75% to Rs 554.35 crore in the quarter ended March 2026 as against Rs 420.77 crore during the previous quarter ended March 2025. Sales rose 11.81% to Rs 3442.93 crore in the quarter ended March 2026 as against Rs 3079.37 crore during the previous quarter ended March 2025. For the full year,net profit declined 3.92% to Rs 1912.93 crore in the year ended March 2026 as against Rs 1990.96 crore during the previous year ended March 2025. Sales rose 16.96% to Rs 14277.64 crore in the year ended March 2026 as against Rs 12207.44 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales3442.933079.37 12 14277.6412207.44 17 OPM %27.0122.19 -25.3424.72 - PBDT905.41746.30 21 3348.613137.55 7 PBT682.33515.43 32 2462.432516.33 -2 NP554.35420.77 32 1912.931990.96 -4 Powered by Capital Market - Live
Mankind Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 2511.4, up 2% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.4% on the day, quoting at 23783.6. The Sensex is at 75701.49, up 0.4%. Mankind Pharma Ltd has gained around 19.34% in last one month. Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has gained around 9.71% in last one month and is currently quoting at 24551.05, up 0.39% on the day. The volume in the stock stood at 7.22 lakh shares today, compared to the daily average of 5.15 lakh shares in last one month. The benchmark May futures contract for the stock is quoting at Rs 2486.3, up 1.66% on the day. Mankind Pharma Ltd is down 2.38% in last one year as compared to a 4.94% slide in NIFTY and a 13.93% slide in the Nifty Pharma index.The PE of the stock is 57.52 based on TTM earnings ending December 25.Powered by Capital Market - Live
Mankind Pharma Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 2439.2, up 2.69% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.67% on the day, quoting at 24164.3. The Sensex is at 77254.26, down 0.76%. Mankind Pharma Ltd has risen around 18.74% in last one month. Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has risen around 9.02% in last one month and is currently quoting at 24135.5, down 0.02% on the day. The volume in the stock stood at 7.39 lakh shares today, compared to the daily average of 4.54 lakh shares in last one month. The benchmark May futures contract for the stock is quoting at Rs 2435.7, up 2.59% on the day. Mankind Pharma Ltd is up 1.29% in last one year as compared to a 0.65% spurt in NIFTY and a 14.52% spurt in the Nifty Pharma index.The PE of the stock is 55.5 based on TTM earnings ending December 25.Powered by Capital Market - Live
Mankind Pharma will hold a meeting of the Board of Directors of the Company on 19 May 2026.
Mankind Pharma Ltd rose for a third straight session today. The stock is quoting at Rs 2353.3, up 1.46% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.06% on the day, quoting at 24018.3. The Sensex is at 76839.15, down 0.23%. Mankind Pharma Ltd has added around 15.35% in last one month. Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has added around 10.1% in last one month and is currently quoting at 23568.95, up 2.16% on the day. The volume in the stock stood at 3.9 lakh shares today, compared to the daily average of 4.18 lakh shares in last one month. The benchmark May futures contract for the stock is quoting at Rs 2361.1, up 1.34% on the day. Mankind Pharma Ltd is down 3.25% in last one year as compared to a 1.62% fall in NIFTY and a 12.19% fall in the Nifty Pharma index.The PE of the stock is 54.22 based on TTM earnings ending December 25.Powered by Capital Market - Live
Mankind Pharma Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 2301.2, up 2.96% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.72% on the day, quoting at 24201.65. The Sensex is at 77776.44, down 0.94%. Mankind Pharma Ltd has added around 15.77% in last one month. Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has added around 3.23% in last one month and is currently quoting at 22455.45, up 2.24% on the day. The volume in the stock stood at 7.66 lakh shares today, compared to the daily average of 5.37 lakh shares in last one month. The benchmark April futures contract for the stock is quoting at Rs 2290.5, up 2.77% on the day. Mankind Pharma Ltd is down 11.47% in last one year as compared to a 0.19% fall in NIFTY and a 4.48% fall in the Nifty Pharma index.The PE of the stock is 52.22 based on TTM earnings ending December 25.
Mankind Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 2188.2, up 2.06% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.72% on the day, quoting at 24539.15. The Sensex is at 79191.47, up 0.85%. Mankind Pharma Ltd has gained around 13.53% in last one month. Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has gained around 1.89% in last one month and is currently quoting at 22456.75, up 0.06% on the day. The volume in the stock stood at 1.76 lakh shares today, compared to the daily average of 5.54 lakh shares in last one month. The benchmark April futures contract for the stock is quoting at Rs 2178.8, up 1.87% on the day. Mankind Pharma Ltd is down 15.17% in last one year as compared to a 1.54% jump in NIFTY and a 4.82% jump in the Nifty Pharma index.The PE of the stock is 50.08 based on TTM earnings ending December 25.
The board of Mankind Pharma at its meeting held on 13 April 2026 has approved the closure/winding-up of Mankind Pharma Lanka, a wholly owned subsidiary (WOS) company incorporated in Sri Lanka, as due to changed regulatory requirements, the anticipated business objectives are no longer viable. There has been no business operations in the aforesaid WOS, and it is not a material subsidiary of the Company.

Over the last 5 years, revenue has grown at a yearly rate of 16.34%, vs industry avg of 10.38%
Over the last 5 years, market share increased from 2.35% to 2.94%
Over the last 5 years, net income has grown at a yearly rate of 14.08%, vs industry avg of 19.71%